The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Stability of curcumin in buffer solutions and characterization of its degradation products
Wang, Y.-J., Pan, M.-H., Cheng, A.-L., Lin, L.-I., Ho, Y.-S., Hsieh, C.-Y., & Lin, J.-K. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,705
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Tønnesen, H. H., Másson, M., & Loftsson, T. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00323-x · Cited by 767
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS
Yang, K.-Y., Lin, L.-C., Tseng, T.-Y., Wang, S.-C., & Tsai, T.-H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.03.010 · Cited by 635
Ireson, C. R., Orr, S., Jones, D. J. L., Verschoyle, R. D., Lim, C. K., Luo, J., Howells, L. M., Plummer, S. M., Jukes, R., Williams, M. L., et al. (2001) · PubMed · Cited by 588
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells
Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., & Tokuda, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00076-2 · Cited by 568
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
Ireson, C. R., Jones, D. J. L., Orr, S., Coughtrie, M. W. H., Boocock, D. J., Williams, M. L., Farmer, P. B., Steward, W. P., & Gescher, A. J. (2002) · PubMed · Cited by 561
Cited by
The Essential Medicinal Chemistry of Curcumin
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00975 · Cited by 1,956
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Improving the Oral Bioavailability of Curcumin Using Novel Organogel-Based Nanoemulsions
Yu, H., & Huang, Q. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf300609p · Cited by 429
Xie, X., Tao, Q., Zou, Y., Zhang, F., Guo, M., Wang, Y., Wang, H., Zhou, Q., & Yu, S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202135j · Cited by 393
Xu, Q., Hong, H., Wu, J., & Yan, X. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.02.050 · Cited by 368
Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention
Bansal, S. S., Goel, M., Aqil, F., Vadhanam, M. V., & Gupta, R. C. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0006 · Cited by 353
Ma, Z., Wang, N., He, H., & Tang, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.053 · Cited by 345
Aditya, N. P., Aditya, S., Yang, H., Kim, H. W., Park, S. O., & Ko, S. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2014.09.131 · Cited by 337
Wound Healing Properties of Selected Natural Products
Ibrahim, N. ‘., Wong, S. K., Mohamed, I. N., Mohamed, N., Chin, K.-Y., Ima-Nirwana, S., & Shuid, A. N. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112360 · Cited by 337
Curcumin, a golden spice with a low bioavailability
Siviero, A., Gallo, E., Maggini, V., Gori, L., Mugelli, A., Firenzuoli, F., & Vannacci, A. (2015) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2015.03.001 · Cited by 333
McClements, D. J., Li, F., & Xiao, H. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032814-014043 · Cited by 315
Curcumin uptake and metabolism
Metzler, M., Pfeiffer, E., Schulz, S. I., & Dempe, J. S. (2013) · BioFactors · doi:10.1002/biof.1042 · Cited by 268
Formulations of Curcumin Nanoparticles for Brain Diseases
Del Prado-Audelo, M. L., Caballero-Florán, I. H., Meza-Toledo, J. A., Mendoza-Muñoz, N., González-Torres, M., Florán, B., Cortés, H., & Leyva-Gómez, G. (2019) · Biomolecules · doi:10.3390/biom9020056 · Cited by 191
“There are two main limitations when curcumin is formulated for therapeutic purposes: limited solubility in water and low permeability [63].”
BackgroundGao, D., Liu, H., Lin, J.-M., Wang, Y., & Jiang, Y. (2013) · Lab on a Chip · doi:10.1039/c2lc41215b · Cited by 135
Khalil, M. N. A., Choucry, M. A., El Senousy, A. S., Hassan, A., El-Marasy, S. A., El Awdan, S. A., & Omar, F. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219378 · Cited by 25
Metadata
- Authors
- Wahlang, B., Pawar, Y. B., & Bansal, A. K.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 77
- Issue
- 2
- Pages
- 275-282
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W1973868951
- Cited by
- 259
- References
- 34
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.